Company filings, made visual.

Find a company. Follow its revenue through costs and profit.

Market

Find a company or ticker

Coverage includes separate ticker and security records; counts are not unique companies.

DaVita Inc.

DVA

Filing: SEC 10-Q
Period: Three months ended March 31, 2026
Basis: Editorial filing; Read original SEC 10-Q ↗

Sankey diagram of DaVita Inc.. A complete text table follows the diagram.

DaVita Converts Dialysis Care Into Patient-Service Revenue

Dialysis services remain the core of DaVita's healthcare platform, with other revenue as a smaller layer.

Swipe to explore

Source & review

Read original SEC 10-Q ↗

SEC accession: 0000927066-26-000062
Filed: Date not recorded
Reviewed: Date not recorded
Status: Individual filing review complete

How to read these figures

Labels and displayed flow values are reported filing values or exact disclosed subtotals.

Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.

The filing reports total revenues of $3,415.548M and other revenues of $142.751M; dialysis is the exact residual.

View accessible tables

Financial categories · Three months ended March 31, 2026 · Millions of USD
Category	Stage	Value	Notes
DaVita Inc. revenue	1	$3.4B	$3,415.5M reported quarterly revenue
Dialysis care platform	2	$3.3B	Exact residual to total revenues
Other revenues	2	$143M	Reported other revenues

Financial flows · Millions of USD
From	To	Value
DaVita Inc. revenue	Dialysis care platform	$3.3B
DaVita Inc. revenue	Other revenues	$143M